“…Overall, the viability of this ex-vivo model to study the acute cardiac effects of VNS was demonstrated.There is growing evidence showing that various pathological conditions are associated with and affected by autonomic imbalances that manifest as dominance of the sympathetic over the parasympathetic activity 1-4 . Therefore, vagus nerve stimulation (VNS) has been considered to be a promising therapeutic approach to treat diverse pathological conditions, such as epilepsy 5-8 , depression 9 , and cardiac diseases 10-14 by restoring the vagal tone to a physiological level.In cardiac medicine, VNS has proven to promote cardioprotective and anti-fibrillatory effects, thus providing a promising therapeutic approach for non-pharmacological treatment of various cardiac pathological conditions, such as ventricular arrhythmias 15 , atrial fibrillation 13 and heart failure 16,17 . However, the fact that VNS is mostly applied to the cervical level due to surgical ease of access and the possibility to target various organ-related fibers, it is often accompanied by difficultly controllable systemic off-target effects [18][19][20] .Although numerous studies have explored diverse effects of VNS on HR and hemodynamic function, invivo 11,[21][22][23][24] and in-situ 10,[25][26][27] , including anti-antiarrhythmic 15 and cardioprotective effects 28 , or alleviation of hypertension 29 , the outcomes are diverse, and the impact of VNS on the cardiac activity is still not fully understood.…”